Concepedia

Biodistributions of 177Lu- and 111In-Labeled 7E11 Antibodies to Prostate-Specific Membrane Antigen in Xenograft Model of Prostate Cancer and Potential Use of 111In-7E11 as a Pre-therapeutic Agent for 177Lu-7E11 Radioimmunotherapy

Mei‐Hsiu Pan, Dongwei Gao, Jinjin Feng, Jiang He, Youngho Seo, J. L. Tedesco, John G. Wolodzko, Bruce H. Hasegawa, Benjamin L. Franc

Molecular Imaging and Biology · 2008 · 32 citations · 15 references

DOIFull text

Open access

Concepts

References

15

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

George L. Wright, B. Mayer Grob, Cara Haley et al. · Urology · 1996 · 630 citations

, , +9

Phase I Trial of <sup>177</sup>Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

Neil H. Bander, Matthew I. Milowsky, David M. Nanus et al. · Journal of Clinical Oncology · 2005 · 508 citations

, , +17

Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides.

John A. O'Donoghue, Manuel Bardiès, T. E. Wheldon · PubMed · 1995 · 378 citations

, , +17

Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids

John K. Trover, Mary Lou Beckett, George L. Wright · International Journal of Cancer · 1995 · 378 citations

, , +14

Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer

Matthew I. Milowsky, David M. Nanus, Lale Kostakoğlu et al. · Journal of Clinical Oncology · 2004 · 313 citations · Full text

, , +17